Moreover, MYB inhibition by RNA interference or MYB‐targeted drugs decreases proliferation and spherogenesis of primary ACC cells and cause downregulation of known MYB target genes [14, 15, 16, 17]. Here, MYB is linked to adrenal cortex carcinoma.